Affinage

LSM4

U6 snRNA-associated Sm-like protein LSm4 · UniProt Q9Y4Z0

Length
139 aa
Mass
15.3 kDa
Annotated
2026-04-28
20 papers in source corpus 12 papers cited in narrative 12 extracted findings

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

LSM4 is a core subunit of the heptameric Lsm1–7 ring that functions in cytoplasmic mRNA decay, P-body assembly, and nuclear pre-mRNA splicing. Its N-terminal Sm fold mediates incorporation into the Lsm ring and is essential for viability, as demonstrated by early embryonic lethality in homozygous knockout mice and yeast complementation studies (PMID:10629062, PMID:11561292, PMID:22615807). The C-terminal low-complexity/RGG domain drives liquid–liquid phase separation and P-body formation through PRMT5-dependent symmetric dimethylation of arginines, and independently contacts SLBP and 3′hExo on the histone mRNP to promote replication-dependent histone mRNA degradation (PMID:27247266, PMID:24255165, PMID:36976747). Symmetric dimethylarginine modifications on LSm4 also mediate binding to the SMN Tudor domain, linking LSm4 to snRNP biogenesis, while an interaction with ICln at the plasma membrane implicates LSm4 in swelling-activated anion channel regulation (PMID:11720283, PMID:19088440).

Mechanistic history

Synthesis pass · year-by-year structured walk · 11 steps
  1. 2000 High

    The question of whether LSm4 is individually essential or redundant with other Lsm proteins was resolved by showing that homozygous Lsm4-knockout mice die shortly after implantation, establishing a non-redundant requirement for LSm4 in early development.

    Evidence Promoter-trap gene targeting and knockout mouse analysis

    PMID:10629062

    Open questions at the time
    • Specific RNA targets or splicing events disrupted in Lsm4-null embryos were not identified
    • Whether lethality reflects loss of splicing, mRNA decay, or both was not resolved
  2. 2001 High

    The discovery that LSm4 carries symmetric dimethylarginine (sDMA) modifications and that these are required for Tudor-domain binding to SMN established a post-translational regulatory axis linking LSm4 to snRNP biogenesis.

    Evidence Mass spectrometry, protein sequencing, in vitro methylation with HeLa extracts, SAH inhibition

    PMID:11720283

    Open questions at the time
    • Whether sDMA modification is constitutive or regulated was not determined
    • Functional consequence of disrupting LSm4–SMN interaction on snRNP assembly was not directly tested
  3. 2001 Medium

    Yeast complementation with C-terminal truncations showed that the Sm-fold domain alone supports viability but the C-terminal domain is essential for stationary-phase survival, delineating two functionally separable domains.

    Evidence Complementation assays with domain truncation mutants in K. lactis and S. cerevisiae

    PMID:11561292

    Open questions at the time
    • Molecular targets of the C-terminal domain in stationary phase were not identified
    • Whether the C-terminal domain function is conserved in mammals was not addressed
  4. 2005 Medium

    Identification of ICln as a physical partner of LSm4 suggested a link between RNA metabolism and cell volume regulation, though the functional significance for LSm4 was initially unclear.

    Evidence Co-immunoprecipitation and NMR structural analysis of ICln PH domain

    PMID:15905169

    Open questions at the time
    • Whether the ICln–LSm4 interaction is direct or bridged was not resolved with purified proteins
    • Functional consequence for RNA processing was not tested
  5. 2008 Medium

    FRET and electrophysiology experiments showed LSm4 resides at the plasma membrane under isotonic conditions and dissociates upon swelling, directly modulating IClswell channel kinetics, thereby establishing a non-canonical function for LSm4 in cell volume regulation.

    Evidence FRET, subcellular fractionation, electrophysiology in NIH3T3 and HEK293 cells

    PMID:19088440

    Open questions at the time
    • Mechanism by which LSm4 inhibits IClswell is unknown
    • Whether this plasma membrane pool is distinct from the mRNA decay pool was not addressed
  6. 2012 High

    Crystal structures of fission yeast Lsm4 confirmed the conserved Sm fold and revealed a monomer–trimer equilibrium, while RNA binding assays showed isolated Lsm4 does not bind RNA, indicating it functions only in the assembled ring context.

    Evidence X-ray crystallography, analytical ultracentrifugation, RNA binding assays with S. pombe Lsm4

    PMID:22615807

    Open questions at the time
    • No structure of the full heptameric ring including Lsm4 was obtained
    • C-terminal low-complexity domain was absent from constructs
  7. 2013 High

    The C-terminal tail of LSm4 was shown to directly contact SLBP and 3′hExo on histone mRNPs, and mutations disrupting these interactions reduced histone mRNA degradation, defining a substrate-specific role for LSm4 beyond general mRNA decay.

    Evidence Co-immunoprecipitation/pulldown, mutagenesis, histone mRNA decay assays upon DNA synthesis inhibition

    PMID:24255165

    Open questions at the time
    • Whether oligouridylation is required upstream of LSm4 engagement was not addressed
    • Structural basis of the C-tail–SLBP/3′hExo interaction is unknown
  8. 2016 High

    Definitive evidence that the LSm4 RGG domain is dispensable for Lsm1–7 assembly, decapping, and mRNA decay but is specifically required for P-body formation established that P-body condensation is mechanistically separable from mRNA decay; PRMT5-mediated sDMA of the RGG domain drives this condensation.

    Evidence RGG deletion rescue, PRMT5 knockdown, fluorescence microscopy, mRNA decay and translation assays in human cells

    PMID:27247266

    Open questions at the time
    • Whether sDMA-dependent P-body formation feeds back to regulate specific mRNAs is unknown
    • The role of the HAT1–RBBP7 interaction identified in this study remains uncharacterized
  9. 2016 Medium

    Genetic epistasis in yeast showed that combined loss of Edc3 and the Lsm4 C-terminal Q/N-rich domain reduces mRNA stability and causes nuclear mislocalization of Dcp2, revealing redundant scaffolding roles of Lsm4 and Edc3 in organizing cytoplasmic mRNA decay.

    Evidence Double mutant analysis, mRNA stability assays, Dcp2 localization in S. cerevisiae

    PMID:27543059

    Open questions at the time
    • Whether the yeast Q/N-rich domain and the mammalian RGG domain are functionally analogous remains formally untested
    • Mechanism of Dcp2 nuclear accumulation is unknown
  10. 2023 Medium

    In vitro reconstitution demonstrated that purified full-length LSm4 undergoes concentration-dependent liquid–liquid phase separation, directly attributing the condensation-driving activity to LSm4 itself rather than to co-factors.

    Evidence Purified recombinant mCherry-LSm4 LLPS assay, hexanediol and salt perturbation, fluorescence microscopy

    PMID:36976747

    Open questions at the time
    • The specific residues or modifications within the low-complexity domain driving LLPS were not mapped by mutagenesis
    • Behavior of LSm4 within the full Lsm1–7 complex in LLPS was not tested
  11. 2025 Medium

    Under hypoxia, reduced tRF-31 binding to LSm4 decreases its ubiquitination and stabilizes the protein, causing nuclear translocation where LSm4 promotes EDN1 pre-mRNA splicing — revealing a tRNA-fragment-based regulatory mechanism governing LSm4 stability and nuclear splicing function.

    Evidence tRF-31 overexpression/knockdown, ubiquitination assays, subcellular fractionation, splicing and proliferation assays in pulmonary artery endothelial cells

    PMID:41354297

    Open questions at the time
    • The E3 ubiquitin ligase targeting LSm4 was not identified
    • Whether tRF-31-mediated regulation applies to other cell types or stress conditions is unknown
    • The specificity of EDN1 as an LSm4 splicing target needs broader transcriptomic validation

Open questions

Synthesis pass · forward-looking unresolved questions
  • Key open questions include the structural basis of the Lsm4 C-terminal domain interactions with SLBP/3′hExo, the identity of the E3 ligase controlling LSm4 turnover, whether P-body condensation driven by LSm4 feeds back to regulate specific mRNA fates, and the physiological relevance of the plasma membrane LSm4–ICln interaction.
  • No structure of the C-terminal RGG/low-complexity domain in complex with any partner
  • No genome-wide identification of LSm4-dependent splicing or decay targets
  • Relationship between PRMT5-dependent sDMA and tRF-31/ubiquitination regulatory axes is unexplored

Mechanism profile

Synthesis pass · controlled-vocabulary classification · explore literature graph →
Molecular activity
GO:0005198 structural molecule activity 3 GO:0003723 RNA binding 2
Localization
GO:0005829 cytosol 3 GO:0005634 nucleus 1 GO:0005886 plasma membrane 1
Pathway
R-HSA-8953854 Metabolism of RNA 3 R-HSA-392499 Metabolism of proteins 2 R-HSA-74160 Gene expression (Transcription) 1
Complex memberships
Lsm1-7 complexLsm2-8 complex (U6 snRNP)

Evidence

Reading pass · 12 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
2001 LSm4 contains symmetrically dimethylated arginine (sDMA) residues in vivo, identified by mass spectrometry and protein sequencing. These sDMA modifications are required for LSm4 binding to the Tudor domain of SMN; inhibition of dimethylation by S-adenosylhomocysteine abolished this interaction. The cytoplasmic PRMT responsible for symmetrical dimethylation of LSm4 was identified in HeLa S100 cytosolic extract. Mass spectrometry, protein sequencing, in vitro methylation assay with HeLa cytosolic/nuclear extracts, synthetic peptide competition, SAH inhibition RNA (New York, N.Y.) High 11720283
2016 The C-terminal RGG domain of human LSm4 promotes processing body (P-body) formation in human cells. Symmetric dimethylation of arginines within the RGG domain by PRMT5 stimulates PB accumulation. An RGG-domain deletion mutant of LSm4 failed to rescue PB formation even though it retained Lsm1-7 assembly, decapping factor association, mRNA decay activity, and translational repression. Depletion of PRMT5 resulted in loss of PBs. The histone acetyltransferase HAT1-RBBP7 complex was identified as a novel interactor of the Lsm4 RGG domain. RGG domain deletion mutagenesis, siRNA depletion of endogenous Lsm4 and PRMT5, rescue experiments, co-immunoprecipitation, fluorescence microscopy of PBs, mRNA decay and translation assays Molecular and cellular biology High 27247266
2013 The C-terminal extension of Lsm4 interacts directly with the histone mRNP, contacting both the stem-loop binding protein (SLBP) and 3'hExo. Mutations in the C-terminal tail of Lsm4 that prevent SLBP and 3'hExo binding reduce the rate of histone mRNA degradation when DNA synthesis is inhibited. Co-immunoprecipitation/pulldown, mutagenesis of C-terminal tail, histone mRNA degradation assays upon DNA synthesis inhibition RNA (New York, N.Y.) High 24255165
2000 Mouse Lsm4 is essential for early embryonic development; homozygous knockout mice survive to blastocyst stage and implant but die shortly thereafter, demonstrating that Lsm4 function in splicing is essential and cannot be compensated by other Lsm proteins. Promoter trap gene targeting in murine ES cells, homozygous knockout mouse analysis Molecular and cellular biology High 10629062
2005 ICln interacts with LSm4 via its pleckstrin homology (PH) domain-like structure, suggesting a physical link between cell volume regulation and RNA splicing/mRNA degradation pathways. Pulldown/co-immunoprecipitation, structural determination of ICln PH domain by NMR The Journal of biological chemistry Medium 15905169
2008 LSm4 associates with ICln and the plasma membrane under isotonic conditions. Upon hypotonic cell swelling, LSm4 dissociates from the plasma membrane and from ICln. Overexpression of LSm4 inhibits ICln translocation to the cell membrane and markedly inhibits the activation kinetics and current density of the swelling-dependent anion channel IClswell, establishing LSm4 as a co-factor in cell volume regulation. FRET, subcellular fractionation biochemistry, electrophysiology, overexpression experiments in NIH3T3 and HEK293 cells Cellular physiology and biochemistry Medium 19088440
2012 Crystal structures of S. pombe Lsm4 (and Lsm3, Lsm5/6/7) were solved, revealing a conserved Sm fold. Lsm4 forms a trimer in the crystal lattice and undergoes dynamic monomer-trimer equilibrium in solution by analytical ultracentrifugation. RNA binding assays showed no direct RNA binding for isolated Lsm4. X-ray crystallography, analytical ultracentrifugation, RNA binding assays PloS one High 22615807
2001 In K. lactis and S. cerevisiae, only the first 72 amino acids of KlLsm4p containing the Sm-like domain are sufficient to restore cell viability in cells lacking wild-type Lsm4, but loss of the carboxy-terminal region causes remarkable loss of viability in stationary phase, establishing a distinct functional role for the C-terminal domain. Complementation assay with C-terminal truncation mutants in K. lactis and S. cerevisiae Yeast (Chichester, England) Medium 11561292
2016 Combined deletion of EDC3 and the Q/N-rich C-terminal region of Lsm4 in S. cerevisiae reduces mRNA stability, increases dependence on Ccr4-mediated deadenylation and mRNA decapping, alters mRNA decay factor levels, and causes nuclear accumulation of the decapping enzyme Dcp2, placing Lsm4's C-terminal domain and Edc3 together in a pathway that regulates mRNA stability and P-body-dependent mRNA fate. Genetic double mutant analysis, mRNA stability assays, subcellular localization of Dcp2, epistasis with deadenylation and decapping pathways in S. cerevisiae Biology open Medium 27543059
2023 Purified full-length human LSm4 protein undergoes concentration-dependent liquid-liquid phase separation (LLPS) in vitro. The C-terminal low-complexity domain is implicated in LLPS. High salt concentrations and 1,6-hexanediol block LLPS, and droplet fusion is observed, consistent with liquid-like properties. In vitro LLPS assay with purified recombinant mCherry-LSm4, fluorescence microscopy (DeltaVision), hexanediol and salt perturbation, disordered region prediction Molekuliarnaia biologiia Medium 36976747
2025 Under hypoxic conditions, reduced tRF-31 binding to LSm4 decreases LSm4 ubiquitination and enhances its protein stability, leading to nuclear translocation of LSm4 where it promotes splicing of EDN1 pre-mRNA. Overexpression of tRF-31 inhibits hypoxia-induced proliferation of pulmonary artery endothelial cells by this mechanism. tRF-31 overexpression/knockdown, LSm4 ubiquitination assay, subcellular fractionation, RNA splicing assay, RNA binding assay (tRF-31 / LSm4 interaction), proliferation assays European journal of pharmacology Medium 41354297
2016 SF3B4 interacts with LSm4 (confirmed by co-immunoprecipitation), and overexpression of LSm4 reverses inhibition of NSCLC cell proliferation, invasion, migration, and stemness caused by SF3B4 knockdown, placing LSm4 downstream of SF3B4 in a cancer-relevant pathway. Co-immunoprecipitation, knockdown rescue by LSm4 overexpression, cell functional assays Thoracic cancer Low 38462740

Source papers

Stage 0 corpus · 20 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
2001 Symmetrical dimethylation of arginine residues in spliceosomal Sm protein B/B' and the Sm-like protein LSm4, and their interaction with the SMN protein. RNA (New York, N.Y.) 313 11720283
2011 Arabidopsis floral initiator SKB1 confers high salt tolerance by regulating transcription and pre-mRNA splicing through altering histone H4R3 and small nuclear ribonucleoprotein LSM4 methylation. The Plant cell 137 21258002
2020 Circ_0025033 promotes the progression of ovarian cancer by activating the expression of LSM4 via targeting miR-184. Pathology, research and practice 60 33285422
2016 The C-Terminal RGG Domain of Human Lsm4 Promotes Processing Body Formation Stimulated by Arginine Dimethylation. Molecular and cellular biology 48 27247266
2005 ICln159 folds into a pleckstrin homology domain-like structure. Interaction with kinases and the splicing factor LSm4. The Journal of biological chemistry 32 15905169
2013 The C-terminal extension of Lsm4 interacts directly with the 3' end of the histone mRNP and is required for efficient histone mRNA degradation. RNA (New York, N.Y.) 29 24255165
2021 AtMC1 Associates With LSM4 to Regulate Plant Immunity Through Modulating Pre-mRNA Splicing. Molecular plant-microbe interactions : MPMI 20 34515495
2001 Isolation and study of KlLSM4, a Kluyveromyces lactis gene homologous to the essential gene LSM4 of Saccharomyces cerevisiae. Yeast (Chichester, England) 20 11561292
2005 HIR1, the co-repressor of histone gene transcription of Saccharomyces cerevisiae, acts as a multicopy suppressor of the apoptotic phenotypes of the LSM4 mRNA degradation mutant. FEMS yeast research 18 16169287
2012 Crystal structures of Lsm3, Lsm4 and Lsm5/6/7 from Schizosaccharomyces pombe. PloS one 15 22615807
2008 LSm4 associates with the plasma membrane and acts as a co-factor in cell volume regulation. Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 15 19088440
2022 Clinical Significance and Potential Role of LSM4 Overexpression in Hepatocellular Carcinoma: An Integrated Analysis Based on Multiple Databases. Frontiers in genetics 12 35096017
2016 The decapping activator Edc3 and the Q/N-rich domain of Lsm4 function together to enhance mRNA stability and alter mRNA decay pathway dependence in Saccharomyces cerevisiae. Biology open 11 27543059
2022 Long noncoding RNA LINC01419 promotes hepatocellular carcinoma malignancy by mediating miR-485-5p/LSM4 axis. The Kaohsiung journal of medical sciences 8 35748489
2015 NEM1 acts as a suppressor of apoptotic phenotypes in LSM4 yeast mutants. FEMS yeast research 8 26316593
2024 METTL3-mediated the m6A modification of SF3B4 facilitates the development of non-small cell lung cancer by enhancing LSM4 expression. Thoracic cancer 7 38462740
2013 A bipolar functionality of Q/N-rich proteins: Lsm4 amyloid causes clearance of yeast prions. MicrobiologyOpen 7 23512891
2000 Peri-implantation lethality in mice lacking the Sm motif-containing protein Lsm4. Molecular and cellular biology 7 10629062
2025 tRF-31-PS5P4PW3FJHP inhibits hypoxia-induced proliferation of pulmonary artery endothelial cells by regulating EDN1 splicing via binding to LSM4. European journal of pharmacology 1 41354297
2023 [Phase Separation of Purified Human LSM4 Protein]. Molekuliarnaia biologiia 0 36976747